Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children-Reference-Cited by-同舟云学术

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

Published:2013-11 Issue:48 Volume:31 Page:5706-5712
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Englund Janet A.,Karron Ruth A.,Cunningham Coleen K.,LaRussa Philip,Melvin Ann,Yogev Ram^ORCID,Handelsman Ed,Siberry George K.,Thumar Bhavanji,Schappell Elizabeth,Bull Catherine V.,Chu Helen Y.,Schaap-Nutt Anne,Buchholz Ursula,Collins Peter L.,Schmidt Alexander C.

Funder

Intramural Research program of the National Institutes of Allergy and Infectious Diseases (NIAID)

NIAID and the Johns Hopkins Bloomberg School of Public Health

National Institutes of Health

National Institute of Allergy and Infectious Diseases (NIAID)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Mental Health (NIMH)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children;Glezen;J Infect Dis,1984

2. Parainfluenza viruses;Chanock,2001

3. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization;Weinberg;J Pediatr,2009

4. Impact of respiratory virus infections on persons with chronic underlying conditions;Glezen;JAMA,2000

5. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection;Peck;Blood,2007

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity;The Journal of Immunology;2024-03-15

2. Evaluation of a Live-Attenuated Human Parainfluenza Virus Type 2 Vaccine in Adults and Children;Journal of the Pediatric Infectious Diseases Society;2023-01-03

3. Paramyxoviruses: Parainfluenza Viruses;Viral Infections of Humans;2023

4. Parainfluenza Viruses;Principles and Practice of Pediatric Infectious Diseases;2023

5. Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household Cohort in Maryland;Clinical Infectious Diseases;2022-12-12